Cosmo Pharmaceuticals Revenue

In the year 2025, Cosmo Pharmaceuticals had annual revenue of 104.17M EUR, down -60.95%. Cosmo Pharmaceuticals had revenue of 51.72M in the half year ending June 30, 2025, with 18.46% growth.

Revenue

104.17M EUR

Revenue Growth

-60.95%

P/S Ratio

10.06

Revenue / Employee

313.78K EUR

Employees

332

Market Cap

1.71B CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	104.17M	-162.61M	-60.95%
Dec 31, 2024	266.79M	174.01M	187.55%
Dec 31, 2023	92.78M	-9.31M	-9.12%
Dec 31, 2022	102.09M	37.02M	56.88%
Dec 31, 2021	65.07M	4.13M	6.77%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Roche Holding AG	63.36B
Novartis AG	44.94B
Galderma Group AG	4.16B
Lonza Group AG	6.53B
Medacta Group	603.41M
Tecan Group AG	906.60M
Aevis Victoria	955.96M
SKAN Group AG	332.13M

Revenue Rankings